| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
132.00(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $539.68 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,506 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,439,266 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
5 |
6 |
7 |
8 |
| Total Sell Transactions |
6 |
8 |
10 |
15 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Stark Leah |
EVP & CHRO |
• – – |
2021-12-30 |
4 |
D |
$467.15 |
$225,166 |
D/D |
(482) |
12,403 |
|
- |
|
| Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2021-12-01 |
4 |
D |
$404.65 |
$31,967 |
D/D |
(79) |
2,725 |
|
- |
|
| Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
• – – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,167 |
22,711 |
|
- |
|
| Kendrick Charles Morgan Jr |
EVP & President, Commercial |
• – – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
525 |
11,474 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• – – |
2021-10-28 |
4 |
S |
$436.00 |
$501,400 |
D/D |
(1,150) |
2,009 |
|
-7% |
|
| Kendrick Charles Morgan Jr |
EVP & President, CommercialOff |
• – – |
2021-10-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,949 |
|
20% |
|
| Alter Jeffrey D. |
EVP, IngenioRx & Anthem Health |
• – – |
2021-10-01 |
4 |
D |
$375.93 |
$116,914 |
D/D |
(311) |
5,107 |
|
- |
|
| Patel Prakash R |
EVP & President, DBG |
• – – |
2021-09-04 |
4 |
D |
$377.71 |
$1,324,629 |
D/D |
(3,507) |
17,230 |
|
- |
|
| Devore Susan D. |
Director |
– • – |
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
416 |
416 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2021-07-23 |
4 |
B |
$384.36 |
$499,668 |
D/D |
1,300 |
4,714 |
2.39 |
6% |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2021-07-02 |
4 |
D |
$387.20 |
$2,146,250 |
D/D |
(5,543) |
25,010 |
|
- |
|
| Dixon Robert L Jr |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
9,471 |
|
- |
|
| Tallett Elizebeth E |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
9,006 |
|
- |
|
| Clark R Kerry |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
7,754 |
|
- |
|
| Peru Ramiro G |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
9,955 |
|
- |
|
| Hay Lewis III |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
9,621 |
|
- |
|
| Neri Antonio F |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
3,039 |
|
- |
|
| Jallal Bahija |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
2,902 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
3,414 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,301 |
51,019 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-05-24 |
4 |
AS |
$393.56 |
$18,340,425 |
D/D |
(46,444) |
54,320 |
|
-5% |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-05-24 |
4 |
OE |
$131.80 |
$8,391,369 |
D/D |
46,444 |
100,764 |
|
- |
|
| Peru Ramiro G |
Director |
– • – |
2021-05-24 |
4 |
AS |
$398.02 |
$520,610 |
D/D |
(1,308) |
9,462 |
|
-5% |
|
| Dixon Robert L Jr |
Director |
– • – |
2021-05-21 |
4 |
S |
$392.87 |
$231,793 |
D/D |
(590) |
8,978 |
|
6% |
|
| Hill Julie A |
Director |
– • – |
2021-05-20 |
4 |
S |
$394.00 |
$515,352 |
D/D |
(1,308) |
31,213 |
|
1% |
|
102 Records found
|
|
Page 4 of 5 |
|
|
3.74 (0.71%) 
